{
    "eid": "2-s2.0-85151561640",
    "title": "Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with \u03b2-thalassaemia/HbE",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "arachidonic acid",
        "deferiprone",
        "iron overload",
        "P-selectin",
        "platelet aggregation",
        "thalassaemia"
    ],
    "authors": [
        "Ngan Thi Tran",
        "Pranee Sutcharitchan",
        "Jindaporn Janprasit",
        "Ponlapat Rojnuckarin",
        "Noppawan Phumala Morales",
        "Rataya Luechapudiporn"
    ],
    "citedby-count": 0,
    "ref-count": 48,
    "ref-list": [
        "Chapter 71 \u2013 Hemoglobinopathies and thalassemias",
        "The impact and disease burden of thalassemia in Thailand: a population-based study in 2010",
        "Pathophysiology and clinical manifestations of the \u03b2-thalassemias",
        "Iron overload in thalassemia: different organs at different rates",
        "Oxygen free radical-dependent increased platelet function in beta-thalassemia major patients",
        "Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C",
        "Thromboembolic complications in beta-thalassemia: beyond the horizon",
        "Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes",
        "The history of deferiprone (L1) and the paradigm of the complete treatment of iron overload in thalassaemia",
        "Deferiprone (GPO-L-ONE(\u00ae)) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand",
        "Deferiprone for the treatment of transfusional iron overload in thalassemia",
        "Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity",
        "Antiplatelet activity of deferiprone through cyclooxygenase-1 inhibition",
        "Pharmacokinetics of deferiprone in patients with \u03b2-thalassaemia: impact of splenectomy and iron status",
        "Comparison of colorimetry and electrothermal atomic absorption spectroscopy for the quantification of non-transferrin bound iron in human sera",
        "Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH",
        "Inhibitory mechanisms of lusianthridin on human platelet aggregation",
        "Aggregation of blood platelets by adenosine diphosphate and its reversal",
        "Thrombosis in thalassemia: why are we so concerned?",
        "Coagulation and splenectomy: an overview",
        "Coagulopathy in Beta-thalassemia: current understanding and future perspectives",
        "Platelet aggregation study in patients with hemoglobin E\u03b2 thalassemia in India",
        "Haemoglobin E beta thalassaemia in Sri Lanka",
        "The molecular mechanism of hemin induce platelet aggregation and secretion",
        "Microparticles from splenectomized \u03b2-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential",
        "The effects of vitamin E on platelet activity in beta-thalassaemia patients",
        "Activated platelets and leukocyte activations in young patients with \u03b2-thalassemia/HbE following bone marrow transplantation",
        "In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites",
        "Platelet activation and platelet-leukocyte interaction in \u03b2-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis",
        "Increase in spontaneous platelet aggregation in beta-thalassemia/hemoglobin E disease: a consequence of splenectomy",
        "Increased circulating platelet aggregates in thalassaemia",
        "Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation",
        "P-selectin and platelet clearance",
        "Biomarkers of platelet activation in acute coronary syndromes",
        "P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation",
        "The role of platelets in inflammation",
        "Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes",
        "Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates",
        "Iron overload and hemolysis modulate monocytes and inflammation in beta-thalassemia",
        "Iron dysregulation in beta-thalassemia",
        "The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in \u03b2-thalassemia/HbE",
        "Protective effect of deferiprone on 7-ketocholesterol formation in hemin-induced LDL oxidation",
        "Treatment of \u03b2-thalassemia/hemoglobin E with antioxidant cocktails results in decreased oxidative stress, increased hemoglobin concentration, and improvement of the hypercoagulable state",
        "Oxidative status of platelets in normal and thalassemic blood",
        "Novel approach to reactive oxygen species in nontransfusion-dependent thalassemia",
        "Role of hydroxyl radicals in the activation of human platelets",
        "Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in beta-thalassemia",
        "Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in \u03b2-thalassemia/ hemoglobin E patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Haiphong",
            "@id": "60109462",
            "affilname": "Haiphong University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109462",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}